IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.127
AS - Asia 7.910
EU - Europa 3.336
SA - Sud America 1.293
AF - Africa 484
Continente sconosciuto - Info sul continente non disponibili 181
OC - Oceania 12
Totale 32.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.641
SG - Singapore 4.911
CN - Cina 1.256
BR - Brasile 1.048
DE - Germania 737
VN - Vietnam 736
IT - Italia 590
FI - Finlandia 553
IE - Irlanda 404
NG - Nigeria 349
CA - Canada 304
FR - Francia 237
IN - India 215
HK - Hong Kong 191
GB - Regno Unito 185
NL - Olanda 136
SE - Svezia 136
TR - Turchia 112
AR - Argentina 89
BD - Bangladesh 78
RU - Federazione Russa 75
MX - Messico 74
IQ - Iraq 66
IL - Israele 63
BE - Belgio 59
PL - Polonia 46
ZA - Sudafrica 39
ES - Italia 35
CL - Cile 34
EC - Ecuador 31
PK - Pakistan 30
CO - Colombia 28
ID - Indonesia 26
JP - Giappone 25
UA - Ucraina 25
JM - Giamaica 22
VE - Venezuela 22
SA - Arabia Saudita 21
MA - Marocco 20
PH - Filippine 19
AE - Emirati Arabi Uniti 17
AT - Austria 16
TN - Tunisia 16
KE - Kenya 15
NI - Nicaragua 15
PY - Paraguay 15
IR - Iran 14
GT - Guatemala 13
KG - Kirghizistan 13
KZ - Kazakistan 13
MY - Malesia 13
NP - Nepal 13
JO - Giordania 12
PE - Perù 12
CZ - Repubblica Ceca 11
CR - Costa Rica 10
EG - Egitto 10
AZ - Azerbaigian 9
HN - Honduras 9
LT - Lituania 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
UY - Uruguay 9
AU - Australia 8
ET - Etiopia 8
EU - Europa 8
KR - Corea 8
RO - Romania 8
UZ - Uzbekistan 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
PA - Panama 7
PT - Portogallo 7
BG - Bulgaria 6
DZ - Algeria 6
EE - Estonia 6
HR - Croazia 5
LB - Libano 5
MD - Moldavia 5
SN - Senegal 5
BY - Bielorussia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
GR - Grecia 3
LV - Lettonia 3
MN - Mongolia 3
MT - Malta 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
BH - Bahrain 2
Totale 32.134
Salva come PNG Salva come JPEG
Città #
Singapore 2.302
Dallas 2.299
Wilmington 2.015
Chandler 1.884
Ashburn 1.066
San Jose 787
San Mateo 776
The Dalles 728
Ann Arbor 609
Helsinki 547
Shanghai 533
Falkenstein 448
Council Bluffs 406
Dublin 401
Leawood 401
Boardman 358
Princeton 350
Benin City 348
Lawrence 327
Beijing 319
New York 315
Ho Chi Minh City 254
Milan 229
Fairfield 197
Toronto 190
Santa Clara 188
Woodbridge 183
Paris 169
Hanoi 168
Los Angeles 164
Hong Kong 156
Amsterdam 118
Pune 99
London 98
Phoenix 97
São Paulo 90
Seattle 84
Kocaeli 80
San Diego 75
Buffalo 74
Rome 71
Brussels 57
Brooklyn 53
Norwalk 51
Chicago 49
Da Nang 48
Atlanta 46
Monmouth Junction 44
North Bergen 44
Rio de Janeiro 44
Houston 43
Warsaw 40
Munich 35
San Francisco 35
Orem 34
Moscow 33
Philadelphia 32
Falls Church 31
Montreal 31
Miami 28
Queens 28
Hillsboro 25
Chennai 24
Haiphong 24
Naples 24
Belo Horizonte 23
Johannesburg 23
Charlotte 22
Columbus 20
Denver 20
Baghdad 19
Boston 19
Campinas 19
Mexico City 19
Figino 18
Brasília 17
Cincinnati 17
Dhaka 17
Hải Dương 17
Jacksonville 17
Newark 17
Pittsburgh 17
Redmond 17
Las Vegas 16
Mumbai 16
Tokyo 16
Bến Tre 15
Stockholm 15
Cleveland 14
Curitiba 14
Kingston 14
Redwood City 14
Sacramento 14
Santiago 14
Goiânia 13
Guayaquil 13
Managua 13
Milwaukee 13
Osasco 13
Porto Alegre 13
Totale 21.484
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 770
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 730
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 708
11Cl-choline PET/CT in imaging locally advanced prostate cancer 690
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 220
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 168
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 163
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 161
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 145
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 139
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 139
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 137
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 136
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 133
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 133
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 130
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 129
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 128
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 128
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 127
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 127
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 124
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 124
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 123
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 120
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 119
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 119
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 119
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 118
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 117
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 116
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 114
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 113
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 113
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery 112
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 112
A risk management approach for imaging biomarker-driven clinical trials in oncology 112
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 112
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 111
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 110
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 109
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 109
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 109
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 109
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 108
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 107
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 106
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 106
PET/CT radiomics in breast cancer: Mind the step 105
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 104
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 104
Exploration of Disease Markers under Translational Medicine Model 103
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 103
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab 103
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 103
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 102
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 101
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 101
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 101
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 101
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 100
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 100
C-11-Methionine uptake in secondary brain epilepsy 99
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 99
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 98
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 98
Assessment of tumor response in malignant pleural mesothelioma 98
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 97
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 97
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 97
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 97
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 97
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data 97
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 96
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables 96
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 96
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 96
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 96
A method to reduce acetonitrile amount in F-18-FDG synthesis 96
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 96
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 96
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units 96
Radiomics of Liver Metastases: A Systematic Review 96
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 96
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 95
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 95
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 95
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 95
Prone scintimammography in patients with non-palpable breast lesions 95
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 95
F-18-FDG PET/CT scans for children and adolescents 94
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 94
Evaluation of response: is F-18-FDG PET the answer? 93
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 93
Nuclear medicine imaging of neuroendocrine tumours 93
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 93
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 93
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 92
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 92
EANM procedure guideline for treatment of refractory metastatic bone pain 91
Totale 13.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.608
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.679 0 0 0 414 37 28 73 260 161 129 486 91
2022/20235.106 748 197 462 560 456 462 10 410 947 432 344 78
2023/20242.627 220 320 583 174 63 301 150 129 51 35 240 361
2024/20253.436 90 71 28 42 62 431 195 380 435 888 414 400
2025/202611.654 1.383 759 1.977 918 281 431 2.914 979 550 533 317 612
2026/20273.692 624 906 1.592 570 0 0 0 0 0 0 0 0
Totale 32.343